Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 26, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From To Commission File Number: 001-32431 DOLBY LABORATORIES, INC. (Exact name of registrant as specified in its charter) Indicate by check mark whether the ...

Dolby Laboratories, Inc. (NYSE:DLB) Q2 2020 Earnings Conference Call May 4, 2020 5:00 PM ET Company Participants Jason Dea - Director of Investor Relations Kevin Yeaman - President and Chief Executive Officer Lewis Chew - Executive Vice President and Chief Financial Officer Conference Call Participants Steven Frankel - Dougherty & Company LLC Eric Wold - B. Riley FBR, Inc. Ralph Schackart - William Blair & Company Paul Chung - JPMorgan Chase & Co. James Goss - Barrington Research Associates, Inc. Operator L ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 27, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From To Commission File Number: 001-32431 DOLBY LABORATORIES, INC. (Exact name of registrant as specified in its charter) | --- | --- | --- | --- | |------- ...

Dolby Laboratories, Inc. (NYSE:DLB) Q1 2020 Results Earnings Conference Call January 29, 2020 5:00 PM ET Company Participants Jason Dea - Director, IR Kevin Yeaman - President and CEO Lewis Chew - EVP and CFO Conference Call Participants Steven Frankel - Dougherty & Company Paul Chung - JPMorgan Jim Goss - Barrington Research Operator Ladies and gentlemen, thank you for standing by. Welcome to the Dolby Laboratories' Conference Call discussing Fiscal First Quarter Results. During the presentation, all parti ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended December 27, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From To Commission File Number: 001-32431 Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 1 ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended September 27, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From To Commission File Number: 001-32431 | --- | --- | --- | |------------------------------------------------------------------------------|------------------ ...

Dolby Laboratories, Inc. (NYSE:DLB) Q4 2019 Earnings Conference Call November 14, 2019 5:00 PM ET Company Participants Jason Dea - Director, IR Kevin Yeaman - President and CEO Lewis Chew - EVP and CFO Conference Call Participants Ralph Schackart - William Blair Steven Frankel - Dougherty Eric Wold - B. Riley Paul Chung - JPMorgan Jim Goss - Barrington Research Operator Ladies and gentlemen, thank you for standing by. Welcome to the Dolby Laboratories' Conference Call discussing Fiscal Fourth Quarter and Fi ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 28, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From To Commission File Number: 001-32431 Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) ...

Dolby Laboratories, Inc. (NYSE:DLB) Q3 2019 Results Earnings Conference Call August 1, 2019 5:00 PM ET Company Participants Jason Dea - Director, IR Kevin Yeaman - President, CEO Lewis Chew - EVP & CFO Conference Call Participants Steven Frankel - Dougherty Ralph Schackart - William Blair Eric Wold - B. Riley Paul Chung - JPMorgan Jim Goss - Barrington Research Operator Ladies and gentlemen, thank you for standing by and welcome to the Dolby Laboratories Conference Call discussing Third Quarter Results. Dur ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 29, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From To Commission File Number: 001-32431 DOLBY LABORATORIES, INC. (Exact name of registrant as specified in its charter) Delaware 90-0199783 (State or othe ...